Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q16635: Variant p.Gly167Arg

Tafazzin
Gene: TAFAZZIN
Feedback?
Variant information Variant position: help 167 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Glycine (G) to Arginine (R) at position 167 (G167R, p.Gly167Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In BTHS; does not affect mitochondrial localization. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 167 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 262 The length of the canonical sequence.
Location on the sequence: help IFPEGKVNMSSEFLRFKWGI G RLIAECHLNPIILPLWHVGM The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         IFPEGKV-----NMSSEFLRFKWGIGRLIAECHLN----PIILPLWHVGM

Gorilla                       IFPEGKV-----NMSSEFLRFKWGIGRLIAECHLN----PI

Rhesus macaque                IFPEGKV-----NMSSEFLRFKWGIGRLIAECHLN----PI

Chimpanzee                    IFPEGKV-----NMSSEFLRFKWGIGRLIAECHLN----PI

Mouse                         IFPEGKV-----NMSSEFLRFKWGIGRLIAECHLN----PI

Zebrafish                     IFPEGRV-----NMSGEFMRIKWGIGRLIAECSLH----PI

Drosophila                    VFPEGKV-----NMDKEELRLKWGVGRIIYESPKI----PI

Slime mold                    IFPEGRI-----SQQTQLLYFKWGLGRLVGECYRRTGVVPL

Baker's yeast                 VYPEGFVLQLYPPFENSMRYFKWGITRMILEATKP----PI
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 262 Tafazzin
Topological domain 36 – 262 Mitochondrial intermembrane
Region 155 – 190 Mitochondrial targeting sequence



Literature citations
Identification of novel mitochondrial localization signals in human Tafazzin, the cause of the inherited cardiomyopathic disorder Barth syndrome.
Dinca A.A.; Chien W.M.; Chin M.T.;
J. Mol. Cell. Cardiol. 114:83-92(2018)
Cited for: SUBCELLULAR LOCATION (ISOFORMS 1 AND 3); MITOCHONDRIAL TARGETING SEQUENCES; CHARACTERIZATION OF VARIANTS BTHS SER-94; ARG-167; ASN-179; ARG-180; PRO-182 AND ARG-184; Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome.
Bleyl S.B.; Mumford B.R.; Thompson V.; Carey J.C.; Pysher T.J.; Chin T.K.; Ward K.;
Am. J. Hum. Genet. 61:868-872(1997)
Cited for: VARIANT BTHS ARG-167;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.